Primary human hepatocytes in spheroid formation to study hepatitis C infection

被引:22
作者
Chong, TW [1 ]
Smith, RL [1 ]
Hughes, MG [1 ]
Camden, J [1 ]
Rudy, CK [1 ]
Evans, HL [1 ]
Sawyer, RG [1 ]
Pruett, TL [1 ]
机构
[1] Univ Virginia, Hlth Sci Ctr, Dept Surg, Surg Infect Dis Lab, Charlottesville, VA 22908 USA
关键词
CD81; human scavenger receptor B1; models; quasispecies;
D O I
10.1016/j.jss.2005.04.043
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Hepatitis C (HCV) is a worldwide health problem, affecting nearly 170 million people. Current models for studying Hepatitis C have focused primarily on the use of poorly permissive cell lines and viral constructs, because of the lack of a suitable animal model or an in vitro system for studying functional infection. As hepatocytes are the primary reservoir for the virus in vivo, we report on a model using primary human hepatocytes cultured in spheroid formation. Materials and methods. The hepatocytes were harvested from uninfected liver resections and cultured as spheroids (that promotes a differentiated phenotype) or monolayers. Spheroids expressed the putative receptors CD81 and human scavenger receptor 131 in a variable pattern throughout the culture period. Samples were inoculated with infectious HCV serum, and HCV RNA was detected using RT-PCR. RNA was detected in the cells and culture medium by 3 days and 5 days after inoculation, respectively. Selection of HVR1 variants occurred in a differential pattern based on culture technique, suggesting that viral selection was dependent on host phenotype. Detection of NS5A by Western blot analysis of infected samples and immunofluorescence for HCV core protein was seen only in infected spheroids. Conclusion. The use of spheroid formation to study Hepatitis C is associated with the establishment of HVR1 selection and functional infection. This represents a promising alternative model to study Hepatitis C. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:52 / 57
页数:6
相关论文
共 27 条
[1]
Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor [J].
Agnello, V ;
Abel, G ;
Elfahal, M ;
Knight, GB ;
Zhang, QX .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12766-12771
[2]
Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets [J].
Barba, G ;
Harper, F ;
Harada, T ;
Kohara, M ;
Goulinet, S ;
Matsuura, Y ;
Eder, G ;
Schaff, Z ;
Chapman, MJ ;
Miyamura, T ;
Brechot, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (04) :1200-1205
[3]
Replication of the hepatitis C virus [J].
Bartenschlager, R ;
Lohmann, V .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2000, 14 (02) :241-254
[4]
Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor [J].
Bartosch, B ;
Vitelli, A ;
Granier, C ;
Goujon, C ;
Dubuisson, J ;
Pascale, S ;
Scarselli, E ;
Cortese, R ;
Nicosia, A ;
Cosset, FL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (43) :41624-41630
[5]
BURDON R, 1991, LAB TECHNIQUES BIOCH
[6]
Alpha interferon inhibits hepatitis C virus replication in primary human hepatocytes infected in vitro [J].
Castet, V ;
Fournier, C ;
Soulier, A ;
Brillet, R ;
Coste, J ;
Larrey, D ;
Dhumeaux, D ;
Maurel, P ;
Pawlotsky, JM .
JOURNAL OF VIROLOGY, 2002, 76 (16) :8189-8199
[7]
Davis GL, 1998, HEPATOLOGY, V28, p390A
[8]
Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein [J].
Farci, P ;
Shimoda, A ;
Wong, D ;
Cabezon, T ;
DeGioannis, D ;
Strazzera, A ;
Shimizu, Y ;
Shapiro, M ;
Alter, HJ ;
Purcell, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (26) :15394-15399
[9]
REINFECTION OF LIVER GRAFT BY HEPATITIS-C VIRUS AFTER LIVER-TRANSPLANTATION [J].
FERAY, C ;
SAMUEL, D ;
THIERS, V ;
GIGOU, M ;
PICHON, F ;
BISMUTH, A ;
REYNES, M ;
MAISONNEUVE, P ;
BISMUTH, H ;
BRECHOT, C .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (04) :1361-1365
[10]
Flint M, 2001, Clin Liver Dis, V5, P873, DOI 10.1016/S1089-3261(05)70199-9